Teresa Tempkin

783 total citations
6 papers, 268 citations indexed

About

Teresa Tempkin is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Neurology. According to data from OpenAlex, Teresa Tempkin has authored 6 papers receiving a total of 268 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Cellular and Molecular Neuroscience, 3 papers in Molecular Biology and 2 papers in Neurology. Recurrent topics in Teresa Tempkin's work include Genetic Neurodegenerative Diseases (5 papers), Pluripotent Stem Cells Research (2 papers) and Neurological disorders and treatments (1 paper). Teresa Tempkin is often cited by papers focused on Genetic Neurodegenerative Diseases (5 papers), Pluripotent Stem Cells Research (2 papers) and Neurological disorders and treatments (1 paper). Teresa Tempkin collaborates with scholars based in United States, Australia and South Korea. Teresa Tempkin's co-authors include Jan A. Nolta, Constance Orme, Martha Nance, Richard H. Myers, Geralyn Annett, Karen Marder, Ira Shoulson, Elise Kayson, Hongqing Zhao and Vicki Wheelock and has published in prestigious journals such as Neurology, Molecular Neurobiology and Cell Transplantation.

In The Last Decade

Teresa Tempkin

6 papers receiving 260 citations

Peers

Countries citing papers authored by Teresa Tempkin

Since Specialization

Citations

This map shows the geographic impact of Teresa Tempkin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Teresa Tempkin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Teresa Tempkin more than expected).

Fields of papers citing papers by Teresa Tempkin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Teresa Tempkin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Teresa Tempkin. The network helps show where Teresa Tempkin may publish in the future.

Co-authorship network of co-authors of Teresa Tempkin

This figure shows the co-authorship network connecting the top 25 collaborators of Teresa Tempkin. A scholar is included among the top collaborators of Teresa Tempkin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Teresa Tempkin. Teresa Tempkin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

6 of 6 papers shown

#	Work	Indexed citations
1	PRE-CELL: Clinical and Novel Biomarker Measures of Disease Progression in a Lead-In-Observational Study for a Planned Phase 1 Trial of Genetically-Modified Mesenchymal Stem Cells Over-Expressing BDNF in Patients with Huntington’s Disease (S25.004) 2016 ·Neurology ·Vicki Wheelock, Teresa Tempkin, (unknown), Amanda Martin, (unknown), (unknown), (unknown), Sarah Farias, (unknown), Charles DeCarli, James A. Brunberg, Chin‐Shang Li, Yu Liu, Mark Yarborough, Julie C. Stout, Miriam Moscovitch‐Lopatin, Steven J. Hersch, Kyle D. Fink, Geralyn Annett, Jan A. Nolta	1
2	Allele-Specific Reduction of the Mutant Huntingtin Allele Using Transcription Activator-Like Effectors in Human Huntington's Disease Fibroblasts 2016 ·Cell Transplantation ·Kyle D. Fink, Peter Deng, (unknown), Joseph S. Anderson, (unknown), (unknown), Stefanos Kalomoiris, Whitney Cary, Johnathon D. Anderson, William Gruenloh, (unknown), Teresa Tempkin, Geralyn Annett, Vicki Wheelock, David J. Segal, Jan A. Nolta	50
3	Developing Stem Cell Therapies for Juvenile and Adult-Onset Huntington's Disease 2015 ·Regenerative Medicine ·Kyle D. Fink, Peter Deng, (unknown), Heather Stewart, Kari Pollock, William Gruenloh, Geralyn Annett, Teresa Tempkin, Vicki Wheelock, Jan A. Nolta	36
4	The Complex Ethics of First in Human Stem Cell Clinical Trials 2012 ·AJOB Neuroscience ·Mark Yarborough, Teresa Tempkin, Jan A. Nolta, Nanette C. Joyce	7
5	Genetically Engineered Mesenchymal Stem Cells as a Proposed Therapeutic for Huntington’s Disease 2011 ·Molecular Neurobiology ·Scott D. Olson, Kari Pollock, Amal Kambal, Whitney Cary, (unknown), (unknown), Heather Stewart, Jeannine McGee, Gerhard Bauer, Hyun Sook Kim, Teresa Tempkin, Vicki Wheelock, Geralyn Annett, Gary Dunbar, Jan A. Nolta	64
6	Predictors of nursing home placement in Huntington disease 2003 ·Neurology ·(unknown), Teresa Tempkin, Karen Marder, Martha Nance, Richard H. Myers, Hongqing Zhao, Elise Kayson, Constance Orme, Ira Shoulson, (unknown)	110

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact